15th Jun 2026 07:54
(Alliance News) - AstraZeneca wins US FDA priority review for kidney drug, while Frasers Group launches a GBP166 million bid for Australian retailer Accent Group and Peel Hunt returns to profit and reinstates its dividend. Elsewhere, Sigma Healthcare withdraws from the Boots sale process. Read More